Trifluridine/tipiracil with and without ramucirumab for advanced gastric cancer: a comparative observational study
2024 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-024-61975-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
46
Citations
4
h-index
0
i10-index
Yasunobu Ishizuka is an academic researcher from Aichi Cancer Center. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies. The author has an h-index of 4, co-authored 24 publications.
https://doi.org/10.1038/s41598-024-61975-7
https://doi.org/10.1093/oncolo/oyae328
https://doi.org/10.1016/j.annonc.2024.10.436
Click to start Chat